O45.019 Premature separation of placenta with afibrinogenemia, unspecified trimester

Name of the Condition

• Premature Separation of Placenta with Afibrinogenemia, Unspecified Trimester (O45.019)

Summary

Premature separation of placenta with afibrinogenemia, unspecified trimester, is a pregnancy complication where the placenta detaches from the uterine wall before delivery, accompanied by a severe deficiency of fibrinogen. This condition disrupts oxygen and nutrient transfer to the fetus and increases the risk of maternal hemorrhage due to impaired blood clotting. Prompt medical intervention is critical to manage maternal and fetal risks.

Causes

The exact cause is often unclear, but it may result from trauma, hypertension, or uterine abnormalities. The afibrinogenemia typically arises from the release of placental tissue into the maternal circulation, triggering abnormal clotting processes and depleting fibrinogen levels.

Risk Factors

• Hypertensive disorders of pregnancy (e.g., preeclampsia).
• Trauma to the abdomen.
• Uterine abnormalities or prior uterine surgery.
• Advanced maternal age.
• Smoking or substance use during pregnancy.
• History of placental abruption.

Symptoms

• Sudden, severe abdominal pain.
• Vaginal bleeding (may be absent in some cases).
• Uterine tenderness or rigidity.
• Fetal distress (e.g., decreased movement, abnormal heart rate).
• Signs of shock (e.g., dizziness, rapid pulse).

Diagnosis

Diagnosis is based on clinical presentation, ultrasound imaging to assess placental separation, and laboratory tests to evaluate coagulation status (e.g., fibrinogen levels, clotting times). Clinical correlation is essential to confirm the condition.

Treatment Options

Treatment focuses on stabilizing the mother and fetus, which may include blood transfusions, fibrinogen replacement, and monitoring for complications. Delivery is often necessary if the pregnancy is viable, with timing dependent on maternal and fetal status.

Prognosis and Follow-Up

Prognosis depends on the severity of placental separation, fibrinogen levels, and fetal gestational age. Close monitoring for hemorrhage and fetal well-being is required. Long-term follow-up may involve assessing for recurrent complications in future pregnancies.

Complications

• Severe maternal hemorrhage.
• Fetal growth restriction or demise.
• Disseminated intravascular coagulation (DIC).
• Maternal or fetal death in severe cases.

Lifestyle & Prevention

• Manage hypertension or other underlying conditions.
• Avoid abdominal trauma.
• Refrain from smoking or substance use during pregnancy.
• Attend regular prenatal care to monitor for early signs.

When to Seek Professional Help

Seek immediate medical attention for sudden abdominal pain, vaginal bleeding, or signs of shock during pregnancy. Prompt evaluation is critical to address potential placental separation and coagulation issues.

Tips for Medical Coders

Document the presence of afibrinogenemia and the unspecified trimester clearly. Ensure clinical correlation supports the diagnosis, as trimester specificity may impact coding accuracy. Verify that placental separation and coagulation defect are appropriately linked in the record.